1 / 26

Preeclampsia Scenario with HELLP & Eclampsia C omplications

Preeclampsia Scenario with HELLP & Eclampsia C omplications. D. Berrin Gunaydin , MD, PhD Ankara , Turkey www.berringunaydin.com. Case presentation. 3 8 yr old nulliparous at 33 1 weeks ’ gestation 67 kg & 161 cm

muncel
Télécharger la présentation

Preeclampsia Scenario with HELLP & Eclampsia C omplications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PreeclampsiaScenariowithHELLP & EclampsiaComplications D. Berrin Gunaydin, MD, PhD Ankara, Turkey www.berringunaydin.com No disclosure

  2. Case presentation • 38 yroldnulliparous at 331weeks’ gestation • 67 kg & 161 cm • SymptomsHeadache, epigastricpain, blurredvision, nausea-vomiting & dizziness • Vitalsigns • BP:190/110 mmHgHR:102 beat/minRR:22 breath/minTemperature: 37.1°C • Physicalexam • Bilateral + pittingedemain lowerextremities

  3. Initialmedicaltreatment IV bolus of 5 mg hydralazineover 2 min IV 5 mg hydralazinerepeatedafter 20 min Blood pressure (BP) decreasedto 170/110 mmHg IV bolus20 mg labetalolover 2 min BP:160/90mmHg, 96 beat/min& 16 breath/min Betamethasone6 mg IM (twice) Continuouscardiotacographymonitoringprovided

  4. Whileplanning her expectantmanagement she had a grandmalseizure

  5. StandardMonitorization • ECG: NSR • HR: 96 beat/min • BP: 160/90 mmHg • Sp02: 98% • RR: 16 breath/min IV bolus MgSO4 4 g in 20 minfollowedby1 g/h IV infusion • 12 h fasting • ASA III-E • Airwayexam: Class II Mallampati • RL infusion 200 mL/h Preoperative Evaluation bg

  6. Management General Anesthesia First leftlateraltilt • After cord clamping IV oxytocin infusionstarted • NewbornwithApgarscores 8 and 9, at 1 & 5 min • Operation lasted 35 min • Residual neuromuscular block antagonized by neostigmine & atropine • Induction • After preoxygenation • IV propofoland rocuronium with RSI • For blunting response to laryngoscopy • IV bolus 5mg labetalol • IV 1.5 mg/kg lidocaine • Maintenance • Sevoflurane 0.75 MAC in 50% NO2/O2 mixture

  7. Followup • Patientwastoldtoreportanysigns/symptomsafterdischargeat home as well • BP monitored 72 hours at thehospital • Discharged on postoperative4 day • Postopretaivemultimodalanalgesia • IV MgSO4continuedfor 24 hours Postoperative Care bg

  8. Plateletcount52,000/µL • AST 331 U/L • ALT 116 U/L • LDH 1524 U/L • Eclampsia • Seizure (+) Diagnosisconfirmed bg

  9. Pathophysiology and Prevalance Overallincidence of HELLP is 2-12% of allpregnancies 20% of preeclampticwomenwith severe features developHELLP

  10. After 20 weeksgestationBP treshold on 2 occasionswith≥ 4 h apart • if BP ≥ 140/90 mmHgformildpreeclampsia • İf BP ≥ 160/110 mmHgfor severe preeclampsia New terminology Hypertension • ≥ 300 mg/24 h in urineorUrineP/C ratio >0.3 Proteinuria Edema ObstetGynecolClin N Am 2017:44:219-30

  11. Cesarean • Platelettransfusionif<50,000/µLbefore CS • Spinal is an appropriate choice • General anesthesia • Continue MgSO4infusion • Smaller ETT tube • Blunt hemodynamic response to intubation Labor • Neuraxial techniques are appropriate as long as platelet function/count are adequate • Early catheter placement • Checking platelet count before catheter removal • Platelettransfusionif< 20,000/µLbefore or after delivery Anesthetic Management: General Principles bg

  12. Drugsbluntinghemodynamicresponsetolaryngoscopy &intubation bg

  13. RevBrasilAnestesiol 2016 AnesthesiaEssaysRes 2017 • CSE(n=50) Spinal(n=12) General(n=37) • Platelet (mean) 112,600/µL 95,700/µL 76,800/µL • ClinExpObstetGynecol 2009 (Retrospectivestudy in 102 preterm HELLP) J AnaesthesiolClinPharmacol 2011 AnesthAnalg2013

  14. Delivery at 37 weeks • 34-37 weeks optimum time topreventmaternal/neonatalmorbidity is unknown • <34 wks’ electivedelivery is NOT considered bg

  15. Methyldopa Diazoxide Labetalol Hydralazine Nifedipine Peripartum AVOIDED SAFE Atenolol ACE inhibitors AT type-2 receptorantagonists (FDA Category C) CritCare 2016 ObstetGynecol N Am 2017 Antihypertensivedrugs bg

  16. Invasivecontinuousintraarterial BP monitoring is indicated • in caseswithpoorlycontrolled HT • rapidneedforloweringBP • forfrequentuse of bloodgases • Central venouspressuremonitoring is advisable • forassessment of oliguriaanditsresponsetofluidadministration Non-invasive modalitiesof haemodynamic measurement such as; lungultrasound,transthoracic echocardiography or pulse waveform monitors Monitoring FHR/Uterinecontractions

  17. MgSO4 is 1st linedrugfor preventionof seizuresinpreeclampsia & ongoingseizures in eclampsia IV bolusloadingdose 4-6 g/100 mLsalineover 20 min IV maintenancedose 1-2 g/h infusion Adverseeffects Hypotension, arrhythmias, respiratorydepression, flushingnausea-vomiting, drowsiness, slurredspeech, doublevision... Prevention-treatment of seizures

  18. Phenylephrine (1) Ephedrine (1,2 andweak ) Noradrenaline (1, ) • 50 µg/mL IV bolus • 5-10 mg/mL IV bolus • 5 µg/mL IV bolus • Optimum initialdose • Target BP • Automatedcomputercontrolledsystems • (bolusand/orinfusion) Vasopressors

  19. SAFE AVOIDED • Oxytocin (bolusand/orinfusion) • ED90=0.35 IU or 2.99 IU • ‘’Rule of threes’’ forinfusion • t1/2 elim ≅ 4-10 min Methergin Ann FrAnesthReanim 2010 • Carbetocin • IV bolus 100 µg • t1/2elim ≅ 20-30 min Uterotonics

  20. MOST recentstudies in severe preeclampsia Airway management Fluidmanagement Use of vasopressors Use of colloidpreload + vasopressors

  21. Airway Management bg

  22. Fluid Management • Colloidvolume had noeffect on HR and CI • Fluidmanagementshould be tailoredtotheindividualpatientwiththeaid of non-invasivehemodynamicmonitoringifavailable bg

  23. Use of vasopressors Fetalacidbasestatus is independent of whetherephedrineorphenylephrineusedtotreatspinalanesthesia inducedhypotensionin severelypreeclampticpatientswithnon-reassuring FHR tracings bg

  24. Use of colloidpreload+vasopressors Phenylephrineeffectivelyreversesspinalanesthesiainducedhemodynamicchanges in severe earlyonsetpreeclampsia, ifleftventricularsystolicfunction is preserved bg

  25. SUMMARY Control of highbloodpressure Prevention & treatment of seizures Monitoring (invasiveornoninvasive) Fluidmanagement Use of uterotonics & vasopressors Anesthesiaoptionsaccordingtocoagulationstatus Longtermramifications!!!!!!!!!!!!

  26. Thank you TakSkal du have bg

More Related